Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter J. Barris currently holds 121,424 shares of Tracon Pharmaceuticals, Inc. (TCON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter J. Barris has been a net buyer of TCON stock. They have purchased $492.7M and sold $359.2M worth of shares.
Peter J. Barris's most recent insider trade was on May 21, 2026, when they sold 5,913 shares at $0.00 per share.
Peter J. Barris serves as Executive at Tracon Pharmaceuticals, Inc. (TCON). They have executed 874 insider transactions totaling $851.9M over their tenure at the company.
Peter J. Barris holds the position of Executive at Tracon Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Peter J. Barris has shown a buying trading pattern, with $492.7M in total purchases and $359.2M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Peter J. Barris was on Jan 22, 2019, when they sold $726.1M worth of TSRO shares. This transaction involved 9,681,038 shares at $75.00 per share.
Peter J. Barris currently owns 121,424 shares of Tracon Pharmaceuticals, Inc. (TCON), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter J. Barris's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter J. Barris has 874 Form 4 filings on record as an insider at Tracon Pharmaceuticals, Inc..
Set alerts for Peter J. Barris and 40,000+ other insiders.